RegInfo: The international database of regulated information of listed companies

SEARCH BY

Issuer directory

KEYWORDS

COMPANIES / ISIN

TYPE OF INFORMATION

INDUSTRY

ADVANCED SEARCH

COMPARTMENTS / INDICES

France

America

Asia

Oceania

> ASX 20
Australia - ASX 20
> NZX 15
New Zealand - NZX 15

Africa

> FTSE/JSE...
South Africa - FTSE/JSE Top 40
> TA 25
Israel - TA 25
- ALONY HETZ
- AZRIELI GROUP
- BAZAN
- BEZEQ
- DELEK DRILLIN
- DELEK GROUP
- DISCOUNT
- ELBIT SYSTEMS
- Energean Oil Gas
- FIBI BANK
- GAZIT GLOBE
- HAREL
- ICL
- IFF
- ISRAEL CORP
- LEUMI
- LivePerson
- MIZRAHI TEFAHOT
- NICE
- OPKO HEALTH
- ORMAT
- PAZ OIL
- PERRIGO
- Phoenix Group Holdings
- POALIM
- SHUFERSAL
- STRAUSS GROUP
- TEVA
- TOWER JAZZ

Europe

PERIODIC INFORMATION

ANNUAL FINANCIAL REPORT	HALF-YEAR FINANCIAL	QUARTERLY INFORMATION
RICHEMONT CREDIT SUISSE CREDIT SUISSE	BARRY CALLEBAUT BARRY CALLEBAUT BARRY CALLEBAUT	UBS ALCON SWISS LIFE
More documents (860)	More documents (656)	More documents (604)
20F	AGM	INTERNAL CONTROL
UBS ABB Ltd NOVARTIS	CLARIANT VIFOR PHARMA VIFOR PHARMA	ROCHE LAFARGE HOLCIM LAFARGE HOLCIM
More documents (4)	More documents (85)	More documents (23)

PERMANENT INFORMATION

2020.09.19 | 16:25 | Permanent Information Releases / General Company News

NOVARTIS

Novartis Piqray® data show survival benefit for patients with HR+/HER2- advanced breast cancer with a PIK3CA mutation - HTML (w)

2020.09.19 | 16:20 | Permanent Information Releases / General Company News

NOVARTIS

Novartis reports late-breaking data from Phase III COMBI-i trial of spartalizumab (PDR001) with Tafinlar® and Mekinist® in advanced melanoma - HTML (w)

2020.09.19 | 16:20 | Permanent Information Releases / General Company News

ROCHE

Roche presents new data from multiple Phase III studies of Tecentriq in triple-negative breast cancer at ESMO Virtual Congress 2020 - HTML (w)

2020.09.18 | 15:20 | Permanent Information Releases / General Company News

ROCHE

Roche receives positive CHMP opinion for Tecentriq in combination with Avastin for the treatment of people with the most common form of liver cancer - HTML (w)

2020.09.18 | 07:03 | Permanent Information Releases / General Company News

ROCHE

Roche launches new quantitative antibody test to measure SARS-CoV-2 antibodies, to support the evaluation of vaccines - HTML (w)

More documents (3421)

Financial transactions

2020.01.06 | 07:00 | Public offerings / Statement of purchases / sales

NOVARTIS

Novartis completes tender offer for all outstanding shares of The Medicines Company - HTML (w)

2019.12.09 | 07:03 | Public offerings / Statement of purchases / sales

ROCHE

Roche and Spark Therapeutics, Inc. announce extension of tender offer for shares of Spark Therapeutics, Inc. to December 16, 2019 - HTML (w)

2019.12.05 | 07:00 | Public offerings / Press Releases during Offer Period

NOVARTIS

Novartis tender offer for The Medicines Company commences - HTML (w)

2019.10.29 | 07:00 | Public offerings / Information note / Note in response

ROCHE

Roche and Spark Therapeutics, Inc. announce extension of tender offer for shares of Spark Therapeutics, Inc. - HTML (w)

2019.07.31 | 07:00 | Public offerings / Press Releases during Offer Period

ROCHE

Roche and Spark Therapeutics, Inc. announce extension of tender offer for shares of Spark Therapeutics, Inc. - HTML (w)

More documents (39)